中国高端医疗装备产业迎来历史性突破：由东软医疗自主研发的NeuVizP10碲锌镉光子计数CT正式获得国家药监局批准上市。这不仅是中国首台光子计 数CT，也是全球首台宽体光子计数CT，它的上市标志着中国在CT影像技术领域实现了从"跟跑"到"领跑"的跨越。 光子计数CT被称为"CT影像领域的第三次革命"，如果说传统CT如用沙漏计量光子，那么光子计数CT就像给每个X射线光子都装上了"身份证"，开启了 CT成像新时代。东软医疗历经十年攻坚，成功研发NeuVizP10，其核心突破在于搭载了碲锌镉光子计数探测器，彻底颠覆了传统CT的成像原理，可直接捕 获并读取单个X射线光子信息，实现"光子直读"，从而带来前所未有的超高空间分辨率、超低辐射剂量和多能量成像效果。 基于一系列颠覆性技术，NeuVizP10将为心血管、肿瘤、神经、呼吸系统等重大疾病的早期诊断带来革命性变革。比如，它能够实现50lp/cm的超高分辨 率，"lp/cm"指的是每厘米内能分辨的线对数，相当于将1厘米分成100份，可以把人体内极为细微的结构都清晰地呈现出来。同时，利用"0"电子噪声特性及 创新算法，在显著提升图像质量的同时，大幅降低辐射剂量和对比剂用量 ...

"东软集团（600718）"微信公众号8月26日消息，近日，由东软集团旗下的创新公司东软医疗自主研发 的NeuViz P10碲锌镉光子计数CT正式获得国家药品监督管理局（NMPA）批准上市。这不仅是中国首台 光子计数CT，也是全球首台8cm宽体光子计数CT，标志着中国在下一代CT技术领域实现了从"跟 跑"到"领跑"的跨越。 据介绍，NeuViz P10的核心革命在于其搭载的碲锌镉（CZT）光子计数探测器，彻底颠覆了传统CT的 成像原理。传统CT采用"X线->闪烁晶体（转换为可见光）->光电二极管（转换为电信号）"的能量积分 模式。NeuViz P10则通过CZT半导体晶体直接捕获并读取单个X射线光子信息，实现"光子直读"，从而 带来前所未有的超高清、超低剂量和多能量成像突破。 基于一系列颠覆性技术，NeuViz P10打造了"光子计数"、"光子超音速"、"光子智能"、"光子科研"四大 平台，全方位重构CT的精准、安全、速度、智能与科研。 目前，东软医疗已携手北京协和医院、四川大学华西医院、中国医科大学附属第一医院、首都医科大学 附属北京天坛医院等顶级三甲医院展开深度临床科研合作，共同探索NeuViz P10在 ...

Core Viewpoint - The introduction of the photon counting spectral CT by United Imaging Healthcare marks a significant technological advancement in the medical imaging field, potentially breaking the foreign monopoly and enhancing China's capabilities in high-end medical equipment [5][18]. Group 1: Technology Overview - Photon counting spectral CT represents a major technological revolution in medical imaging, providing new diagnostic dimensions that significantly enhance precision in diagnosis [5]. - Unlike traditional CT, which uses indirect detection methods, photon counting spectral CT employs semiconductor detectors for direct photoelectric conversion, allowing for precise energy information recognition of each X-ray [8][11]. - The spatial resolution of photon counting CT can reach 0.2 mm, which is 2-3 times finer than traditional CT, enabling clearer visualization of small structures and early detection of micro lesions [8][10]. Group 2: Clinical Applications - Photon counting CT can display finer vascular branches and narrow areas in head and neck examinations, reduce metal artifacts in cardiac imaging, and assist in early detection of ground-glass nodules and small airway diseases in lung examinations [9][12]. - It allows for energy imaging, enabling the differentiation of high atomic number substances and providing quantitative assessments of tissue components, which enhances tumor diagnosis and treatment evaluation [10][11]. Group 3: Market Potential - The domestic market price for photon counting CT is around 50 million yuan per unit, indicating its position in the ultra-high-end market [16]. - The global photon counting CT market is projected to grow from approximately 77 million USD in 2022 to 1.1 billion USD by 2029, with a compound annual growth rate of 46.1%, presenting significant growth opportunities for United Imaging Healthcare [22]. Group 4: Company Strategy and Performance - United Imaging Healthcare has established a core strategy focused on high-end medical imaging equipment, achieving significant milestones since its inception, including the launch of various innovative imaging technologies [19][21]. - In 2024, United Imaging Healthcare is expected to generate total revenue of 10.3 billion yuan, with a net profit of 1.262 billion yuan, reflecting a growth in market share despite potential demand mismatches [21].

Core Viewpoint - The latest stock price of United Imaging Healthcare is 129.15 yuan, reflecting a slight increase of 0.47% from the previous trading day, with significant developments in their photon-counting spectral CT technology [1] Company Overview - United Imaging Healthcare specializes in the research and manufacturing of high-end medical imaging equipment, including CT, MR, and DR devices [1] - The company has recently launched its self-developed photon-counting spectral CT for clinical testing at Zhongshan Hospital and Ruijin Hospital, which significantly enhances imaging resolution and reduces radiation dosage by up to 90% [1] Technological Advancements - The photon-counting spectral CT project is a key initiative under the "14th Five-Year Plan" by the Ministry of Science and Technology, achieving breakthroughs in semiconductor detectors and overall system design [1] - This technology aims to assist doctors in early detection of small lesions, thereby improving diagnostic capabilities [1] Market Potential - The global market size for photon-counting spectral CT was approximately 75.31 million USD in 2022, with projections to grow to 1.1 billion USD by 2029 [1] Financial Insights - On the trading day, the net inflow of main funds was 17.22 million yuan, accounting for 0.02% of the circulating market value, while the net outflow over the past five days totaled 35.97 million yuan, representing 0.05% of the circulating market value [1]